Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 144 Insider Sale of Securities
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 4 Grant or award Director acquired 10,690 shares (grant or award)
  4. 4 Grant or award COO and SVP, Compliance acquired 91,631 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 282,529 shares (grant or award)
  6. 4 Grant or award Director acquired 10,690 shares (grant or award)
  7. 4 Grant or award Director acquired 10,690 shares (grant or award)
  8. 4 Grant or award Director acquired 10,690 shares (grant or award)
  9. 4 Grant or award Director acquired 10,690 shares (grant or award)
  10. 4 Grant or award Director acquired 10,690 shares (grant or award)
  11. 8-K Event Results of operations · Regulation FD disclosure
  12. 4 Planned sale President and CEO sold 21,000 shares at $19.79 ($415,590)
  13. 4 Planned sale President and CEO sold 21,000 shares at $16.00 ($336,000)
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Planned sale President and CEO sold 21,000 shares at $16.00 ($336,000)
  17. 144 Insider Sale of Securities
  18. UPLOAD Other SEC-generated Letter
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. 4 Planned sale President and CEO sold 21,000 shares at $16.13 ($338,730)

Page 3 of 50 · 1,000 filings